BioSpace News Archive

Spend base reduction of $2.5 billion since initiation of the restructuring plan in 2018; on-track to achieve $3.0 billion by the end of 2019

Abbott (NYSE: ABT) announced today that m-PIMA™ HIV-1/2 VL, the world’s first point-of-care viral load diagnostic test, has received the World Health Organization’s Prequalification approval (WHO PQ).

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced financial results for the first quarter 2019

Manhattan Scientifics Inc., is pleased to announce that the company has completed an exclusive license and transfer of specialty machines to a large American metals manufacturer who provides specialty metals to the U.S. and global medical industry.

Medit, a high-precision 3D scanning solutions provider, announced that the Medit i500 intraoral scanner has won the Red Dot Award: Product Design 2019.

CirrusMD, a chat-first virtual care solution, today announced that it has raised $15 million in a Series B round of funding led by Drive Capital, Colorado Impact Fund and other prior investors, bringing total funding to-date to $26 million.

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and gene therapies, (“BioLife” or the “Company”), today announced that the Company’s first quarter 2019 financial results will be released after market close on Thursday, May 9, 2019,

More than 175 Advocates Take Action Together in the Nation’s Capital to END EPILEPSY®

Today, the American Urological Association (AUA), a leading global urology association, released a new clinical guideline on the diagnosis and treatment of early stage testicular cancer.

Alliance for Better Health senior leader will help group develop a standardized terminology set for expansion of ICD-10 Z codes